Amoxycillin/clavulanic acid

DRUG4 trials

Sponsors

UPECLIN HC FM Botucatu Unesp, TASK Applied Science, All India Institute of Medical Sciences, Monash University

Conditions

Community-Acquired PneumoniaLeukemiaMyelomaNeutropenia, FebrileNon Hodgkin's LymphomaPediatric CancerPulmonary Tuberculosis

Phase 2

Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis

CompletedNCT02349841

TASK Applied SciencePulmonary Tuberculosis

Start: 2014-09-30End: 2014-12-31Updated: 2018-09-13

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)

RecruitingNCT07202091

Monash UniversityLeukemia, Myeloma, Non Hodgkin's Lymphoma

Start: 2025-05-06End: 2027-03-31Target: 900Updated: 2025-10-07

Phase 3

Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study

TerminatedNCT03003273

All India Institute of Medical SciencesNeutropenia, Febrile, Pediatric Cancer

Start: 2017-01-31End: 2018-12-31Target: 142Updated: 2019-02-01

Phase 4

Comparison Between Amoxycillin/Clavulanic Acid and Oxacillin/Ceftriaxone for Community Acquired-pneumonia

CompletedNCT01166932

UPECLIN HC FM Botucatu UnespCommunity-Acquired Pneumonia

Start: 2005-04-30End: 2009-04-30Updated: 2010-11-01